Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Bijl

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Plos One|March 24, 2015
Cell membrane integrity in myotonic dystrophy type 1: implications for therapyAnchel González-Barriga, Julia Kranzen, Huib J E Croes, et al.
Nucleic Acid Therapeutics|April 10, 2023
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular DystrophyJudith van Deutekom, Chantal Beekman, Suzanne Bijl, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Plos One|March 24, 2015
Cell membrane integrity in myotonic dystrophy type 1: implications for therapyAnchel González-Barriga, Julia Kranzen, Huib J E Croes, et al.
Nucleic Acid Therapeutics|April 10, 2023
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular DystrophyJudith van Deutekom, Chantal Beekman, Suzanne Bijl, et al.
Pageof 2